Collaborations in Cancer and HIV Cure Research
The HIV Cure & Cancer Forum brought cancer and HIV researchers together in Paris, as a prelude to the International AIDS Society Conference on HIV Science. The forum explored overlaps between the...
Making the cut: CRISPR gene editing and HIV
CRISPR/cas9 is a gene-editing strategy acting like a targeted pair of scissors. The technology has generated a lot of excitement, especially in the field of HIV. This is because it can target specific...
Locking in HIV – can silencing lead to cure?
During primary infection, HIV naturally establishes latency in specialised immune cells, mainly CD4 T cells. A research group led by Professor Anthony Kelleher and Dr Chantelle Ahlenstiel from the...
Has a functional cure been discovered in Queensland?
A functional cure for HIV may have been discovered in Queensland. That’s the hope of Brisbane researchers who have created an antiviral protein that appears to ‘switch off’ the virus. The...
Study attempts double HIV block by gene transfer
A bold study to make cells resistant to HIV is now recruiting in Sydney. Researchers from the Kirby Institute have paired with the HIV biotech firm, Calimmune, to conduct a small human study of...
HIV evades gene editing attempts
A new study shows that using gene scissors to remove HIV from an infected cell may not be as effective as hoped. Several years ago, it was shown that specialised gene scissors could remove specific...
HIV-1 genomes eliminated from T cells
Scientists at the Lewis Katz School of Medicine at Temple University in Philadelphia have designed a gene-editing system that may hold the answer for an eventual cure for people living with HIV. The...
First trial to use umbilical cord stem cells to cure HIV
The world’s first clinical trial which aims to cure five HIV patients within three years using transplants of blood from umbilical cords is set to start in Spain. The project seeks to be the...
.png)